...
tmdx-img

TransMedics Group Inc, Common Stock

TMDX

NMQ

$63.9

+$1.25

(2%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.07B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
66.3441
Volume info-icon
This is the total number of shares traded during the most recent trading day.
438.31K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.07
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$59.72 L
$177.37 H
$63.9

About TransMedics Group Inc, Common Stock

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameTMDXSectorS&P500
1-Week Return-4.65%-0.33%-1.49%
1-Month Return-20.27%-4.57%-0.37%
3-Month Return-59.84%-9.96%3.89%
6-Month Return-55.41%-5.67%9.34%
1-Year Return-22.36%2.53%25.19%
3-Year Return203.54%-1.43%24.7%
5-Year Return228.7%34.73%85.39%
10-Year Return180.19%102.14%187.19%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue23.60M25.64M30.26M93.46M241.62M[{"date":"2019-12-31","value":9.77,"profit":true},{"date":"2020-12-31","value":10.61,"profit":true},{"date":"2021-12-31","value":12.52,"profit":true},{"date":"2022-12-31","value":38.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue9.74M9.00M9.10M28.19M87.53M[{"date":"2019-12-31","value":11.13,"profit":true},{"date":"2020-12-31","value":10.29,"profit":true},{"date":"2021-12-31","value":10.4,"profit":true},{"date":"2022-12-31","value":32.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit13.86M16.64M21.16M65.27M154.09M[{"date":"2019-12-31","value":9,"profit":true},{"date":"2020-12-31","value":10.8,"profit":true},{"date":"2021-12-31","value":13.73,"profit":true},{"date":"2022-12-31","value":42.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin58.73%64.88%69.92%69.84%63.77%[{"date":"2019-12-31","value":84,"profit":true},{"date":"2020-12-31","value":92.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.89,"profit":true},{"date":"2023-12-31","value":91.21,"profit":true}]
Operating Expenses43.47M43.02M60.59M96.71M182.82M[{"date":"2019-12-31","value":23.78,"profit":true},{"date":"2020-12-31","value":23.53,"profit":true},{"date":"2021-12-31","value":33.14,"profit":true},{"date":"2022-12-31","value":52.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(29.60M)(26.38M)(39.43M)(31.44M)(28.73M)[{"date":"2019-12-31","value":-2960300000,"profit":false},{"date":"2020-12-31","value":-2638400000,"profit":false},{"date":"2021-12-31","value":-3942800000,"profit":false},{"date":"2022-12-31","value":-3143700000,"profit":false},{"date":"2023-12-31","value":-2872700000,"profit":false}]
Total Non-Operating Income/Expense(8.26M)(6.32M)(8.63M)(8.45M)(6.14M)[{"date":"2019-12-31","value":-825700000,"profit":false},{"date":"2020-12-31","value":-631700000,"profit":false},{"date":"2021-12-31","value":-862500000,"profit":false},{"date":"2022-12-31","value":-845400000,"profit":false},{"date":"2023-12-31","value":-613700000,"profit":false}]
Pre-Tax Income(33.51M)(28.72M)(44.18M)(36.16M)(26.67M)[{"date":"2019-12-31","value":-3350700000,"profit":false},{"date":"2020-12-31","value":-2871600000,"profit":false},{"date":"2021-12-31","value":-4417900000,"profit":false},{"date":"2022-12-31","value":-3616500000,"profit":false},{"date":"2023-12-31","value":-2667100000,"profit":false}]
Income Taxes40.00K32.00K36.00K66.00K(1.64M)[{"date":"2019-12-31","value":60.61,"profit":true},{"date":"2020-12-31","value":48.48,"profit":true},{"date":"2021-12-31","value":54.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2489.39,"profit":false}]
Income After Taxes(33.55M)(28.75M)(44.22M)(36.23M)(25.03M)[{"date":"2019-12-31","value":-3354700000,"profit":false},{"date":"2020-12-31","value":-2874800000,"profit":false},{"date":"2021-12-31","value":-4421500000,"profit":false},{"date":"2022-12-31","value":-3623100000,"profit":false},{"date":"2023-12-31","value":-2502800000,"profit":false}]
Income From Continuous Operations(33.55M)(28.72M)(44.22M)(36.23M)(35.78M)[{"date":"2019-12-31","value":-3354700000,"profit":false},{"date":"2020-12-31","value":-2871600000,"profit":false},{"date":"2021-12-31","value":-4421500000,"profit":false},{"date":"2022-12-31","value":-3623100000,"profit":false},{"date":"2023-12-31","value":-3577900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(33.55M)(28.75M)(44.22M)(36.23M)(25.03M)[{"date":"2019-12-31","value":-3354700000,"profit":false},{"date":"2020-12-31","value":-2874800000,"profit":false},{"date":"2021-12-31","value":-4421500000,"profit":false},{"date":"2022-12-31","value":-3623100000,"profit":false},{"date":"2023-12-31","value":-2502800000,"profit":false}]
EPS (Diluted)(6.38)(1.20)(1.61)(1.25)(0.77)[{"date":"2019-12-31","value":-638,"profit":false},{"date":"2020-12-31","value":-120,"profit":false},{"date":"2021-12-31","value":-161,"profit":false},{"date":"2022-12-31","value":-125,"profit":false},{"date":"2023-12-31","value":-77,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TMDX
Cash Ratio 5.50
Current Ratio 8.20
Quick Ratio 7.33

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TMDX
ROA (LTM) 2.84%
ROE (LTM) 19.41%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TMDX
Debt Ratio Lower is generally better. Negative is bad. 0.73
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.27

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TMDX
Trailing PE 66.34
Forward PE 52.08
P/S (TTM) 5.16
P/B 9.87
Price/FCF NM
EV/R 5.63
EV/Ebitda 34.89

FAQs

What is TransMedics Group Inc share price today?

TransMedics Group Inc (TMDX) share price today is $63.9

Can Indians buy TransMedics Group Inc shares?

Yes, Indians can buy shares of TransMedics Group Inc (TMDX) on Vested. To buy TransMedics Group Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TMDX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of TransMedics Group Inc be purchased?

Yes, you can purchase fractional shares of TransMedics Group Inc (TMDX) via the Vested app. You can start investing in TransMedics Group Inc (TMDX) with a minimum investment of $1.

How to invest in TransMedics Group Inc shares from India?

You can invest in shares of TransMedics Group Inc (TMDX) via Vested in three simple steps:

  • Click on Sign Up or Invest in TMDX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in TransMedics Group Inc shares
What is TransMedics Group Inc 52-week high and low stock price?

The 52-week high price of TransMedics Group Inc (TMDX) is $177.37. The 52-week low price of TransMedics Group Inc (TMDX) is $59.72.

What is TransMedics Group Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of TransMedics Group Inc (TMDX) is 66.3441

What is TransMedics Group Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of TransMedics Group Inc (TMDX) is 9.87

What is TransMedics Group Inc dividend yield?

The dividend yield of TransMedics Group Inc (TMDX) is 0.00%

What is the Market Cap of TransMedics Group Inc?

The market capitalization of TransMedics Group Inc (TMDX) is $2.07B

What is TransMedics Group Inc’s stock symbol?

The stock symbol (or ticker) of TransMedics Group Inc is TMDX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top